EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Device-detected atrial fibrillation in a large remote-monitored cohort: implications for anticoagulation and need for new pathways of service delivery

Catherine J O'Shea, Anthony G Brooks, Melissa E Middeldorp, Curtis Harper, Jeroen M Hendriks, Andrea M Russo, James V Freeman, Rakesh Gopinathannair, Niraj Varma, Thomas F Deering, Kevin Campbell, Prashanthan Sanders

Journal of Interventional Cardiac Electrophysiology · 2023

DOI: 10.1007/s10840-023-01481-4 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Interventional Cardiac Electrophysiology, 2023. Verfasst von Catherine J O'Shea und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia. Hauptthemen laut MEDLINE: Atrial Fibrillation, Defibrillators, Implantable, Pacemaker, Artificial. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Remote monitoring (RM) can facilitate early detection of subclinical and symptomatic atrial fibrillation (AF), providing an opportunity to evaluate the need for stroke prevention therapies. We aimed to characterize the burden of RM AF alerts and its impact on anticoagulation of patients with device-detected AF.

Methods

Consecutive patients with a cardiac implantable electronic device, at least one AF episode, undergoing RM were included and assigned an estimated minimum CHA 2 DS 2 -VASc score based on age and device type. RM was provided via automated software system, providing rapid alert processing by device specialists and systematic, recurrent prompts for anticoagulation.

Results

From 7651 individual, 389,188 AF episodes were identified, 3120 (40.8%) permanent pacemakers, 2260 (29.5%) implantable loop recorders (ILRs), 987 (12.9%) implantable cardioverter defibrillators, 968 (12.7%) cardiac resynchronization therapy (CRT) defibrillators, and 316 (4.1%) CRT pacemakers. ILRs transmitted 48.8% of all AF episodes. At twelve-months, 3404 (44.5%) AF < 6 min, 1367 (17.9%) 6 min–6 h, 1206 (15.8%) 6–24 h, and 1674 (21.9%) ≥ 24 h. A minimum CHA 2 DS 2 -VASc score of 2 was assigned to 1704 (63.1%) of the patients with an AF episode of ≥ 6 h, 531 (31.2%) who were not anticoagulated at 12-months, and 1031 (61.6%) patients with an AF episode duration of ≥ 24 h, 290 (28.1%) were not anticoagulated.

Conclusions

Despite being intensively managed via RM software system incorporating cues for anticoagulation, a substantial proportion of patients with increased stroke risk remained unanticoagulated after a device-detected AF episode of significant duration. These data highlight the need for improved clinical response pathways and an integrated care approach to RM.

Trial registration

Australian New Zealand Clinical Trial Registry: ACTRN12620001232921. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationDefibrillators, ImplantablePacemaker, ArtificialHumansAnticoagulantsAustraliaRisk Factors

Stichwörter der Autor:innen

AnticoagulationAtrial fibrillationCardiac implantable electronic deviceRemote monitoring

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia.
  • Department of Cardiology, Royal Adelaide Hospital, Adelaide, Australia.
  • PaceMate, Bradenton, FL, USA.
  • Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, Australia.
  • Cooper Medical School of Rowan University, Camden, NJ, USA.
  • Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.

Förderung

  • NCATS NIH HHS

Zitieren

APA

O'Shea, C. J., Brooks, A. G., Middeldorp, M. E., Harper, C., Hendriks, J. M., Russo, A. M., Freeman, J. V., Gopinathannair, R., Varma, N., Deering, T. F., Campbell, K., & Sanders, P. (2023). Device-detected atrial fibrillation in a large remote-monitored cohort: implications for anticoagulation and need for new pathways of service delivery. Journal of Interventional Cardiac Electrophysiology. https://doi.org/10.1007/s10840-023-01481-4

Vancouver

O'Shea CJ, Brooks AG, Middeldorp ME, Harper C, Hendriks JM, Russo AM, et al. Device-detected atrial fibrillation in a large remote-monitored cohort: implications for anticoagulation and need for new pathways of service delivery. Journal of Interventional Cardiac Electrophysiology. 2023. doi:10.1007/s10840-023-01481-4

BibTeX
@article{OShea2023,
  author = {O'Shea, Catherine J and Brooks, Anthony G and Middeldorp, Melissa E and Harper, Curtis and Hendriks, Jeroen M and Russo, Andrea M and Freeman, James V and Gopinathannair, Rakesh and Varma, Niraj and Deering, Thomas F and Campbell, Kevin and Sanders, Prashanthan},
  title = {Device-detected atrial fibrillation in a large remote-monitored cohort: implications for anticoagulation and need for new pathways of service delivery},
  journal = {Journal of Interventional Cardiac Electrophysiology},
  year = {2023},
  doi = {10.1007/s10840-023-01481-4}
}
Kostenlos starten →